Cargando…
MicroRNAs and metabolic disorders – where are we heading?
MicroRNAs (miRNAs, miRs) are short, non-coding molecules engaged in normal functioning of eukaryotic cells, as negative regulators of gene expression. Since the first discovery of miRNA in the early 1990s, hundreds of different miRNAs and their targets have been identified. A growing number of studi...
Autores principales: | Sliwinska, Agnieszka, Kasinska, Marta A., Drzewoski, Jozef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507111/ https://www.ncbi.nlm.nih.gov/pubmed/28721157 http://dx.doi.org/10.5114/aoms.2017.65229 |
Ejemplares similares
-
Epigenetic modifications in adipose tissue – relation to obesity and diabetes
por: Kasinska, Marta A., et al.
Publicado: (2015) -
Psychiatric manifestations of neurologic disease: where are we headed?
por: Lyketsos, Constantin G., et al.
Publicado: (2007) -
Immunosuppression in kidney transplant recipients with COVID-19 infection – where do we stand and where are we heading?
por: Daoud, Ahmed, et al.
Publicado: (2021) -
The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
por: Włodarski, Adam, et al.
Publicado: (2020) -
Heart failure in the diabetic population – pathophysiology, diagnosis and management
por: Kasznicki, Jacek, et al.
Publicado: (2014)